Search results

Skip to results

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Showing 1 to 3 of 3 results for birch bark extract

  1. Birch bark extract for treating epidermolysis bullosa (HST28)

    Evidence-based recommendations on birch bark extract (Filsuvez) for treating partial thickness wounds associated with dystrophic and junctional epidermolysis bullosa in people aged 6 months and over.

    Highly specialised technologies guidance
    Published
    20 September 2023
    View recommendations

    Sections for HST28

  2. Beremagene geperpavec for treating skin wounds associated with dystrophic epidermolysis bullosa [ID3959]

    In development [GID-TA10868] Expected publication date: 29 January 2026

    Technology appraisal guidance
    In development

  3. NICE recommends novel treatment for debilitating inherited skin condition

    Around 670 people in England with skin wounds caused by a rare inherited disorder to benefit from a new treatment to help the healing process.

    News
    Last updated
    18 January 2024